Terbinafine Treatment for Tinea Cruris

Oral Terbinafine Treatment

• For children 20-40 kg, the recommended dose is 125 mg once daily for 2-4 weeks, according to the British Journal of Dermatology 2
• For children <20 kg, the recommended dose is 62.5 mg once daily for 2-4 weeks, as per the British Journal of Dermatology 2
• Short treatment duration with oral terbinafine improves patient compliance compared to longer treatment regimens, as noted by the Pediatrics journal 1

Safety Considerations

• Common side effects of terbinafine include gastrointestinal disturbances and dermatological reactions, as reported by Praxis Medical Insights 3
• Terbinafine is contraindicated in patients with lupus erythematosus, as stated by the British Journal of Dermatology 2
• Terbinafine is also contraindicated in patients with porphyria, according to the British Journal of Dermatology 2

Topical Terbinafine Treatment

• Topical treatment is appropriate for limited disease without hair follicle involvement, as recommended by the Pediatrics journal 1

Important Clinical Considerations

• Complete drying of the crural folds after bathing helps prevent recurrence, as advised by the Pediatrics journal 1
• The endpoint of treatment should be mycological rather than just clinical cure, as emphasized by the British Journal of Dermatology 4
• Treatment failure may be due to poor compliance, suboptimal drug absorption, or organism insensitivity, as noted by the British Journal of Dermatology 2